Whitefort Capital Sends Letter To Arbutus Biopharma Board Of Directors; Believes Now Is The Time For Arbutus To Pursue A License And Collaboration Agreement With A Strategic Partner And Explore All Options For HBV Portfolio
Whitefort Capital Sends Letter To Arbutus Biopharma Board Of Directors; Believes Now Is The Time For Arbutus To Pursue A License And Collaboration Agreement With A Strategic Partner And Explore All Options For HBV Portfolio
Whitefort Capital Management, LP (together with its affiliates, "Whitefort Capital," "us" or "we"), which is a long-term investor and the third largest shareholder of Arbutus Biopharma Corp. (NASDAQ:ABUS) ("Arbutus" or the "Company") with an ownership interest of approximately 6.8% of the Company's outstanding shares, today published a letter to the Company's Board of Directors (the "Board") outlining its views on the actions Arbutus must take in order to preserve and maximize shareholder value.Believes Now Is the Logical Time for Arbutus to Pursue a License and Collaboration Agreement With a Strategic Partner and Explore All Options for HBV Portfolio
认为现在是arbutus biopharma与战略合作伙伴签订许可和合作协议，探索HBV投资组合的所有选择的合适时机
Urges Arbutus to Commit to No Dilutive Equity Issuances or ATM Use for Another Year
敦促arbutus biopharma承诺在另一年内不进行股权稀释或ATm使用
Whitefort Formally Requests Meeting With the Board to Ensure Alignment of Views on Path Forward
Whitefort正式请求与董事会会面，以确保对未来道路的观点保持一致
Whitefort Capital Management, LP (together with its affiliates, "Whitefort Capital," "us" or "we"), which is a long-term investor and the third largest shareholder of Arbutus Biopharma Corp. (NASDAQ:ABUS) ("Arbutus" or the "Company") with an ownership interest of approximately 6.8% of the Company's outstanding shares, today published a letter to the Company's Board of Directors (the "Board") outlining its views on the actions Arbutus must take in order to preserve and maximize shareholder value.
Whitefort资本管理有限合伙公司（连同其关联公司、“Whitefort资本”、“我们”或“我们”）是arbutus biopharma corp.（纳斯达克：ABUS）（“arbutus”或“公司”）的长期投资者，也是arbutus biopharma corp.的第三大股东，持有公司流通股的约6.8%，今天发布了一封致公司董事会（“董事会”）的信函，概述arbutus必须采取的行动，以维护并最大化股东价值。